We are live on ! Find out more
T

TOBAM Portfolio holdings

AUM $384M
1-Year Est. Return 10.32%
This Fund
S&P 500
This Quarter Est. Return
+4.72%
1 Year Est. Return
+10.32%
3 Year Est. Return
+36.67%
5 Year Est. Return
+41.37%
10 Year Est. Return
+233.72%
AUM
$548M
AUM Growth
-$89.4M
Cap. Flow
-$107M
Cap. Flow %
-19.59%
Top 10 Hldgs %
24.74%
Holding
348
New
22
Increased
127
Reduced
117
Closed
29

Top Buys

1
DXCM icon
DexCom
DXCM
+$7.61M
2
EW icon
Edwards Lifesciences
EW
+$5.3M
3
CMG icon
Chipotle Mexican Grill
CMG
+$4.47M
4
DG icon
Dollar General
DG
+$4.1M
5
LPLA icon
LPL Financial
LPLA
+$3.22M

Top Sells

1
K
Kellanova
K
+$13.1M
2
MKTX icon
MarketAxess Holdings
MKTX
+$8.31M
3
NEM icon
Newmont
NEM
+$7.69M
4
LLY icon
Eli Lilly
LLY
+$6.64M
5
UTHR icon
United Therapeutics
UTHR
+$6.19M

Sector Composition

1 Healthcare 32.67%
2 Consumer Staples 19.07%
3 Technology 15.04%
4 Financials 9.84%
5 Communication Services 8.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
T icon
1
AT&T
T
$157B
$15.8M 2.88%
716,919
-282,135
-28% -$5.61M
GIS icon
2
General Mills
GIS
$21B
$14.8M 2.7%
200,417
-60,014
-23% -$4.16M
CBOE icon
3
Cboe Global Markets
CBOE
$29.4B
$13.9M 2.54%
67,899
-27,906
-29% -$5.48M
UTHR icon
4
United Therapeutics
UTHR
$22.7B
$13.6M 2.48%
37,941
-18,317
-33% -$6.19M
ABBV icon
5
AbbVie
ABBV
$460B
$13.4M 2.45%
67,967
-24,660
-27% -$4.6M
LLY icon
6
Eli Lilly
LLY
$1.05T
$13.1M 2.39%
14,784
-7,388
-33% -$6.64M
CHD icon
7
Church & Dwight Co
CHD
$23.9B
$12.9M 2.36%
123,364
-35,855
-23% -$3.68M
MCK icon
8
McKesson
MCK
$101B
$12.9M 2.35%
26,089
-2,565
-9% -$1.43M
CLX icon
9
Clorox
CLX
$12.1B
$12.9M 2.35%
79,077
-30,010
-28% -$4.45M
MRK icon
10
Merck
MRK
$324B
$12.4M 2.26%
109,101
-381
-0.3% -$45.3K
HUM icon
11
Humana
HUM
$47.5B
$11.5M 2.1%
36,383
-8,782
-19% -$3.13M
VZ icon
12
Verizon
VZ
$187B
$11.4M 2.09%
254,864
-59,663
-19% -$2.49M
PFE icon
13
Pfizer
PFE
$146B
$11.4M 2.08%
393,919
-117,436
-23% -$3.43M
BMY icon
14
Bristol-Myers Squibb
BMY
$127B
$10.8M 1.97%
209,106
-9,203
-4% -$432K
JNJ icon
15
Johnson & Johnson
JNJ
$614B
$10.8M 1.97%
66,722
-11,732
-15% -$1.87M
SJM icon
16
J.M. Smucker
SJM
$12.5B
$10M 1.83%
82,867
-31,377
-27% -$3.7M
LPLA icon
17
LPL Financial
LPLA
$26.5B
$9.79M 1.78%
42,074
+14,307
+52% +$3.22M
CPB icon
18
Campbell Soup
CPB
$6.94B
$9.02M 1.65%
184,459
-67,162
-27% -$3.27M
KR icon
19
Kroger
KR
$36.8B
$8.8M 1.61%
153,642
-79,235
-34% -$4.25M
ALNY icon
20
Alnylam Pharmaceuticals
ALNY
$37.6B
$8.65M 1.58%
31,467
+1,736
+6% +$452K
NBIX icon
21
Neurocrine Biosciences
NBIX
$17.3B
$8.44M 1.54%
73,246
-17,219
-19% -$2.36M
NEM icon
22
Newmont
NEM
$96B
$8.28M 1.51%
154,930
-154,777
-50% -$7.69M
ANET icon
23
Arista Networks
ANET
$202B
$8.24M 1.5%
85,852
-54,000
-39% -$4.7M
HRL icon
24
Hormel Foods
HRL
$14.4B
$8.01M 1.46%
252,604
-71,909
-22% -$2.28M
DVA icon
25
DaVita
DVA
$15B
$7.22M 1.32%
44,068
-15,768
-26% -$2.33M
1
2 3 4 5

Similar funds

PCM
Pinnbrook Capital Management New York $384M AUM 147.48% 1-Year Est. Return
DFA
Delta Financial Advisors New Orleans, Louisiana $384M AUM 26.86% 1-Year Est. Return
BAMG
Brand Asset Management Group Chesterfield, Missouri $385M AUM 22.41% 1-Year Est. Return
DR
Davis Rea Toronto, Ontario, Canada $384M AUM 11.74% 1-Year Est. Return
GCP
Garda Capital Partners Wayzata, Minnesota $385M AUM 7.25% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
GA
GSG Advisors Mount Laurel, New Jersey $385M AUM 19.83% 1-Year Est. Return
VI
VectorGlobal IAG Miami, Florida $385M AUM

TOBAM's Q3 2024 Portfolio in Review

As of Q3 2024, TOBAM held 348 positions worth $548M, down 14% from $638M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

TOBAM withdrew a net $107M in Q3 2024, closing 29 positions and reducing 117 holdings. Its most notable exit was Kellanova, an estimated $13.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 31% a quarter earlier, followed by Consumer Staples and Technology.

Against the trend, TOBAM opened a new position in Incyte worth $878K.

  • TOBAM's largest Q3 2024 buy was Incyte: 13,276 shares worth $878K.
  • TOBAM added most to DexCom in Q3 2024, an estimated $7.61M increase.
  • TOBAM's biggest Q3 2024 reduction was Newmont, cutting an estimated $7.69M.
  • TOBAM fully exited Kellanova in Q3 2024, selling an estimated $13.1M.
  • TOBAM's ten largest holdings make up 25% of its $548M portfolio in Q3 2024.
  • TOBAM opened 22 new positions and closed 29 in Q3 2024.
  • TOBAM's portfolio value fell 14% quarter-over-quarter to $548M.

Based on TOBAM's 13F filing for Q3 2024, filed 9 Oct 2024.